Disc Stem Cell Amplification Using Growth Factors

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for treating intervertebral degenerative disc disease, such as discectomy and artificial disc insertion, face challenges in effectively regenerating disc tissue due to the harsh biomechanical and biological environment of the disc, where non-disc cells and stem cells fail to survive and function appropriately, leading to limited success in tissue engineering approaches.

Innovation Solution

A method for amplifying and enriching disc stem cell populations using specific growth factors and culture conditions, including basic fibroblast growth factor (bFGF) and epidermal growth factor (EGF), to isolate and expand disc stem cells that can form discospheres and clusters, capable of differentiating into functional nucleus pulposus cells for tissue regeneration.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Quantity of substance

If non-disc cells or stem cells are used for tissue engineering, then cell availability is improved, but cell survival and functionality deteriorate in the harsh disc environment

Engineering Contradiction:
Improvecell availabilityVSAvoidcell survival and functionality
Core Design Contradiction:
Quantity of substanceVSReliability

Solution Approach 1:

The patent changes the biochemical parameters of the culture medium by adding specific growth factors (bFGF, EGF, TGF-beta) and adjusting serum concentration to create an optimized culture environment that maintains stem cell viability and promotes differentiation into disc-specific cell types, thereby resolving the contradiction between cell availability and cell survival

Inventive Principle:
Principle #35Parameter changes

2Reliability

If nucleus pulposus cells are used for regeneration, then disc-specific functionality is improved, but proliferative capacity deteriorates due to limited division ability

Engineering Contradiction:
Improvedisc-specific functionalityVSAvoidproliferative capacity
Core Design Contradiction:
ReliabilityVSProductivity

Solution Approach 1:

The patent uses stem cells as a preliminary source that can be expanded in culture before differentiation into nucleus pulposus cells. This preliminary expansion step generates sufficient cell numbers while maintaining the ability to differentiate into functional disc cells, resolving the contradiction between functionality and proliferative capacity

Inventive Principle:
Principle #10Preliminary action

3Reliability

If stem cells are manipulated in vitro for differentiation, then cell functionality is improved, but proliferative potential deteriorates

Engineering Contradiction:
Improvecell functionalityVSAvoidproliferative potential
Core Design Contradiction:
ReliabilityVSProductivity

Solution Approach 1:

The patent employs periodic medium changes and staged differentiation protocols where cells are first expanded under conditions maintaining high proliferative potential, then gradually exposed to differentiation-inducing factors. This periodic approach to culture and differentiation maintains both functionality and proliferative potential

Inventive Principle:
Principle #19Periodic action

Data Source

PatentUS9657270B2Human disc tissue
Publication Date: 2017.05.23 DISCGENICS INC
  • US9657270B2 patent drawing
  • US9657270B2 patent drawing
  • US9657270B2 patent drawing

AI summary

This invention provides disc stem cells, processes for obtaining and culturing disc stem cells, and methods for repairing damaged or diseased disc tissue comprising the use of the disc stem cells of the invention.